20 stories about Healthtech
RedDress Alon

RedDress raises $26 million to heal chronic wounds with product created from patient's own blood

The company has developed an autologous, point-of-care wound management solution that creates an in-vitro blood clot from patients’ own whole blood
יעל פלד ו אדם ויוני שטיין חברת לגונה הלת' Laguna Health

Laguna Health lands $15 million Series A for AI-powered contextual care platform

The Israeli startup’s AI engine integrates medical care plans with social, emotional, and cultural factors to help care managers better support members' recovery and ongoing care
דודי דויד ישראלי מג'נטה מדיקל

Magenta Medical raises $55 million for world’s smallest heart pump

03.05.23|Meir Orbach
The Israeli company’s device is a powerful heart pump that is initially folded, inserted through the groin using a small puncture, and expanded for activation inside the left ventricle

Healthtech startup Neteera secures $13 million Series B for contactless patient monitoring

Neteera’s technology is designed to enable continuous monitoring of patients’ bio markers without the need for contact or patient involvement, streamlining patient monitoring, improving outcomes, and reducing the burden on clinical staff
רפואה עתידנות ביג דאטה דיגיטל

Israeli healthtech startups raised $2.8 billion in 2022, but tech crisis threatens growth

While healthtech is not immune to the overall macroeconomic environment, it proved to be more resilient in 2022, with capital raised in the sector declining by just 13% compared to other high-tech sectors which experienced a collective decline of 43%
Protai Founders

Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline

The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches
Brachie Sprung Chief Communications Officer and Head of IR at Amoon

“I once got asked who is home with my kids, it’s an offensive question a man would never be asked”

15.02.23|Noa Gadot
Brachie Sprung, Chief Communications Officer & Head of IR at healthtech and life sciences investment fund aMoon, has always been the underdog, but that only made her more hungry for success
וועידת הרי - פאנל כיצד המשקיעים רואים את עתיד הרפואה

"When we look at investment, it is first and foremost a money decision. But we also look to make the world a better place"

11.12.22|James Spiro
A panel of physicians and VCs gathered during The Future Health Matrix in Tel Aviv held by the Israel Medical Association (IMA) to discuss investment opportunities in the future of medicine
וועידת הרי דר אוטמר קלויבר

How AI plays its role in medical innovation

11.12.22|James Spiro
Speaking at The Future Health Matrix conference hosted by Israel Medical Association (IMA) in Tel Aviv, Dr. Otmar Kloiber, Secretary General of the World Medical Association, addressed the risks and benefits of AI in medical innovation
aMoon Partners

“Global spend on healthcare is, by and large, recession-proof”

11.12.22|Elihay Vidal, James Spiro
aMoon Velocity’s Roy Wiesner and Yaniv Sadka joined CTech to share some predictions for the year ahead.
מנכ"ל ארליסנס לשעבר מאט ג'ונסון ועו"ד אופיר רונן המייצג את העובדים

An early demise: The sad end of Israel’s EarlySense

21.11.22|Meir Orbach
The company, which developed sensors for hospital beds, fell into debt and went into receivership. The last of the company's employees submitted a request to open proceedings for fear of losing their money
Navina team

Navina raises $22 million Series B to transform primary care

27.10.22|Meir Orbach
The Israeli startup uses medically-informed AI to provide primary care physicians with the right information at the right time
מייסדי סייטוריזן, מימין: דוד הראל, פרופ' שי שן-אור, אלינה סטרוסבצקי, רנו גוז'ו

CytoReason raises $20 million from Pfizer for AI drug discovery and development platform

20.09.22|Meir Orbach
Pfizer will also have options to license the Israeli startup’s platform and disease models, and fund supplementary project support, in a deal potentially worth up to $110 million over the next five years
Guy Goldman Olive Diagnostics

Olive Diagnostics extends Seed round to $7.3 million for AI-powered real-time urine analysis device

The Israeli startup received the CE Marking in Europe for its AI-powered optical urine analysis device which measures red blood cells, proteins, ketones, Nitrite, and pH

Theranica secures $45 million Series C to treat migraines

The Israeli company has developed an FDA-cleared, smartphone-controlled, drug-free wearable device named Nerivio for the treatment of episodic and chronic migraine
קירה רדינסקי דוקטור מדענית ראשית של אי ביי ebay

Kira Radinsky’s Diagnostic Robotics raises $45 million Series B

25.07.22|Sophie Shulman
The Israeli startup, which has developed an AI platform that helps predict which patients will benefit from proactive interventions and improve the point of care, has doubled its valuation to several hundred million dollars since its last funding round in 2019
דותן אסלמן תמיר וולף Tamir Wolf Dotan Asselmann Theator

Surgical intelligence platform Theator extends Series A with additional $24 million

The Israeli startup's surgical intelligence platform institutionalizes the routine capture of surgical video data, harnessing AI and computer vision to automatically analyze every operation
David Salton Virility Medical

Virility Medical raises $10 million to treat premature ejaculation

21.07.22|Meir Orbach
The Israeli company’s method uses an intimate, drug-free, skin patch based on EMS (Electrical Muscle Stimulation) and claims to be far superior to other medical interventions such as medication, which can cause side effects